Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-11-25
1987-11-17
Bond, Robert T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 20, A61K 31395, C07D52100
Patent
active
047074841
ABSTRACT:
Compounds of the formula ##STR1## wherein R.sub.1 is hydrogen, lower alkyl or acyl; R.sub.2 and R.sub.3 independently are lower alkyl, aralkyl or alkenyl or R.sub.2 and R.sub.3 together form a ring of 5 to 8 carbon atoms; R.sub.4 is phenyl, substituted phenyl, cyclohexyl, substituted cyclohexyl, cyclopentyl, substituted cyclopentyl, cycloheptyl, or substituted cycloheptyl; R.sub.5 is hydrogen or lower alkyl; R.sub.6 is hydrogen, lower alkyl or acyl; and pharmaceutically acceptable acid addition salts thereof are described. The compounds of formula I and pharmaceutically acceptable acid addition salts thereof are anti-emetic agents which lack central nervous system side effects.
REFERENCES:
patent: 3467755 (1969-09-01), Schoen et al.
patent: 3759927 (1973-09-01), Huebner
Berger Leo
Dairman Wallace M.
Mowles Thomas F.
Olson Gary L.
Bond Robert T.
Boxer Matthew
Hoffmann-La Roche Inc.
Leon Bernard S.
Saxe Jon S.
LandOfFree
Substituted piperidinomethylindolone and cyclopent(b)indolone de does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted piperidinomethylindolone and cyclopent(b)indolone de, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted piperidinomethylindolone and cyclopent(b)indolone de will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1450369